1. Home
  2. ATRA vs KOSS Comparison

ATRA vs KOSS Comparison

Compare ATRA & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • KOSS
  • Stock Information
  • Founded
  • ATRA 2012
  • KOSS 1953
  • Country
  • ATRA United States
  • KOSS United States
  • Employees
  • ATRA N/A
  • KOSS N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • KOSS Consumer Electronics/Appliances
  • Sector
  • ATRA Health Care
  • KOSS Consumer Staples
  • Exchange
  • ATRA Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • ATRA 51.1M
  • KOSS 49.5M
  • IPO Year
  • ATRA 2014
  • KOSS N/A
  • Fundamental
  • Price
  • ATRA $11.58
  • KOSS $5.52
  • Analyst Decision
  • ATRA Strong Buy
  • KOSS
  • Analyst Count
  • ATRA 4
  • KOSS 0
  • Target Price
  • ATRA $20.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • ATRA 57.7K
  • KOSS 381.8K
  • Earning Date
  • ATRA 08-11-2025
  • KOSS 08-28-2025
  • Dividend Yield
  • ATRA N/A
  • KOSS N/A
  • EPS Growth
  • ATRA N/A
  • KOSS N/A
  • EPS
  • ATRA N/A
  • KOSS N/A
  • Revenue
  • ATRA $199,732,000.00
  • KOSS $12,433,361.00
  • Revenue This Year
  • ATRA N/A
  • KOSS N/A
  • Revenue Next Year
  • ATRA N/A
  • KOSS N/A
  • P/E Ratio
  • ATRA N/A
  • KOSS N/A
  • Revenue Growth
  • ATRA 475.53
  • KOSS N/A
  • 52 Week Low
  • ATRA $5.01
  • KOSS $4.00
  • 52 Week High
  • ATRA $18.71
  • KOSS $10.55
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 66.87
  • KOSS 52.64
  • Support Level
  • ATRA $8.53
  • KOSS $5.23
  • Resistance Level
  • ATRA $13.46
  • KOSS $8.59
  • Average True Range (ATR)
  • ATRA 0.96
  • KOSS 0.47
  • MACD
  • ATRA 0.28
  • KOSS 0.06
  • Stochastic Oscillator
  • ATRA 62.65
  • KOSS 14.01

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: